Original Article Anesthesiology Pediatric Surgery Quality Improvement
Does telemedicine follow-up reduce falls in adults with type 2 diabetes? A systematic review and meta-analysis

Does telemedicine follow-up reduce falls in adults with type 2 diabetes? A systematic review and meta-analysis

Authors

Lucas Ibrahim

Lucas Ibrahim

Charité Berlin, Hong Kong S.A.R.

Daniel Novak

Daniel Novak

Toronto General Hospital, Slovenia

Corresponding
Mei Moreau

Mei Moreau

Mayo Clinic, Guernsey

Adam Andersen

Adam Andersen

Singapore General Hospital, Costa Rica

Lina Nakamura

Lina Nakamura

American University of Beirut Medical Center, Mali

Published

November 25, 2023

Paper ID

PAP-000114

Status

Published

DOI

10.65712/tmj.test000372

Does telemedicine follow-up reduce falls in adults with type 2 diabetes? A systematic review and meta-analysis

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: falls remains a leading cause of avoidable harm among adults with type 2 diabetes. Methods: We conducted a systematic review and meta-analysis across 9 centres between 2014 and 2025. Results: falls occurred in 21% of the intervention group versus 13% of controls. Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.

Introduction

falls remains a leading cause of avoidable harm among adults with type 2 diabetes. Practice around telemedicine follow-up varies widely between centres.

Guidelines make only a weak recommendation on telemedicine follow-up. The cost of falls to health systems is substantial. falls remains a leading cause of avoidable harm among adults with type 2 diabetes.

falls remains a leading cause of avoidable harm among adults with type 2 diabetes. Earlier studies of telemedicine follow-up were small or single-centre.

Guidelines make only a weak recommendation on telemedicine follow-up. Earlier studies of telemedicine follow-up were small or single-centre. falls remains a leading cause of avoidable harm among adults with type 2 diabetes.

Materials and Methods

We conducted a systematic review and meta-analysis across 6 centres between 2020 and 2022. The primary outcome was falls, assessed blind to allocation. We conducted a systematic review and meta-analysis across 3 centres between 2015 and 2022.

Missing data were handled with multiple imputation. The primary outcome was falls, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.

Analyses were adjusted for age, sex and baseline severity. Eligible participants were adults with type 2 diabetes. We conducted a systematic review and meta-analysis across 3 centres between 2020 and 2022.

Missing data were handled with multiple imputation. The primary outcome was falls, assessed blind to allocation. Eligible participants were adults with type 2 diabetes.

Results

Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.52 (95% CI 0.29 to 0.99).

Effects were consistent across prespecified subgroups. falls occurred in 18% of the intervention group versus 20% of controls. The adjusted odds ratio was 0.72 (95% CI 0.34 to 0.98).

4391 participants were included (median age 52 years). falls occurred in 7% of the intervention group versus 34% of controls. falls occurred in 14% of the intervention group versus 13% of controls. Effects were consistent across prespecified subgroups.

GroupnEventsRate %OR
Age ≥ 65832614.40.54
Centre B5136331.50.53
Age < 65666485.80.61
Female1427428.60.75
Male7495513.60.43
Age < 65510326.30.41
Centre A810318.00.81
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Kaplan–Meier curve for falls
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Trend in falls
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. falls occurred in 9% of the intervention group versus 29% of controls. 1738 participants were included (median age 62 years).

Discussion

Strengths include the sample size and blinded outcome assessment. Future work should test telemedicine follow-up in a pragmatic multicentre trial. These findings suggest that telemedicine follow-up is associated with better falls in adults with type 2 diabetes.

Future work should test telemedicine follow-up in a pragmatic multicentre trial. These findings suggest that telemedicine follow-up is associated with better falls in adults with type 2 diabetes.

Residual confounding cannot be excluded. These findings suggest that telemedicine follow-up is associated with better falls in adults with type 2 diabetes.

These findings suggest that telemedicine follow-up is associated with better falls in adults with type 2 diabetes. Future work should test telemedicine follow-up in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.

Conclusions

Telemedicine follow-up may be offered for adults with type 2 diabetes to improve falls.

References

1. Tanaka V, Ahmed F, et al. Nurse-led discharge planning and glycaemic control. JAMA. 2016;161(5):413-1138.

2. Moreau E, Rahman T, et al. Point-of-care ultrasound and 30-day readmission. Lancet. 2016;290(2):561-962.

3. Patel T, Schmidt N, et al. Vitamin D supplementation and ventilator-free days. Ann Intern Med. 2023;370(5):124-1007.

4. Schmidt H, Kowalski V, et al. Delayed cord clamping and glycaemic control. Pediatrics. 2018;31(2):741-1676.

5. Osei F, Tanaka B, et al. An enhanced recovery pathway and emergency department revisits. Pediatrics. 2012;108(12):171-1523.

6. Okafor V, Zhang D, et al. High-flow nasal oxygen and chronic pain scores. JAMA. 2018;282(3):885-1687.

7. Kowalski C, Herrera Q, et al. An enhanced recovery pathway and chronic pain scores. Eur Heart J. 2020;236(9):56-1504.

8. Rossi X, Yilmaz B, et al. Nurse-led discharge planning and medication adherence. Crit Care Med. 2025;36(2):863-1260.

9. Zhang Y, Haddad M, et al. Low-dose aspirin and falls. BMC Med. 2017;49(9):647-1047.

10. Costa S, Rahman N, et al. Nurse-led discharge planning and medication adherence. Crit Care Med. 2014;229(12):385-1512.

11. Okafor C, Farouk V, et al. SGLT2 inhibitors and medication adherence. Crit Care Med. 2020;279(6):807-1456.

Appendices

Ethics approval: IRB-5957.